Novocure Reports Third Quarter 2019 Financial Results and Provides Company Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Novocure (NVCR) Tops Q3 EPS by 7c, Revenues Beat
October 31, 2019 6:40 AM EDTNovocure (NASDAQ: NVCR) reported Q3 EPS of $0.02, $0.07 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $92.1 million versus the consensus estimate of $87.08 million.
Quarterly net revenues of $92.1 million, representing 42% growth versus the third quarter 2018First quarter ever of positive net income with $0.02 in earnings per shareContinued clinical... More